Market Tracker

01/22 6:37am ET

Merck & Co Inc (NYSE:MRK)

61.28
Delayed Data
As of Jan 19
 +0.15 / +0.25%
Today’s Change
53.63
Today|||52-Week Range
66.80
+8.90%
Year-to-Date
Cancer Space Update: Label Expansions, Data Readouts in Focus
Jan 19 / Zacks.com - Paid Partner Content
Merck Soars as Lung Cancer Study Meets Goals
Jan 16 / TheStreet.com - Paid Partner Content
Will J&J's (JNJ) Pharma Segment Pull Up its Q4 Earnings?
Jan 19 / Zacks.com - Paid Partner Content
General Motors Updates Guidance on Tuesday
Jan 16 / GuruFocus News - Paid Partner Content
Here's Why Nektar Stock Skyrocketed Almost 500% in a Year
Jan 19 / Zacks.com - Paid Partner Content
Dow Finishes Lower After Surpassing 26,000; S&P 500 and Nasdaq Also Decline
Jan 16 / TheStreet.com - Paid Partner Content
Pharma Stock Roundup: Merck's Keytruda Shines in Study, Priority Review for Kymriah L...
Jan 19 / Zacks.com - Paid Partner Content
AstraZeneca's Lynparza Label Now Includes Breast Cancer
Jan 15 / Zacks.com - Paid Partner Content
Jolley Asset Management, LLC Buys Merck Inc, Axalta Coating Systems, Roche Holding AG...
Jan 18 / GuruFocus News - Paid Partner Content
Ligand (LGND) Inks Deal With Glenmark for OmniAb Platform
Jan 12 / Zacks.com - Paid Partner Content
BioLineRx Cancer Drug Positive as Monotherapy in Phase IIa
Jan 18 / Zacks.com - Paid Partner Content
Dow 30 Stock Roundup: Boeing Q4 Deliveries Up Y/Y, Success for Merck's Keytruda Combo
Jan 12 / Zacks.com - Paid Partner Content
J&J (JNJ) to Set Pharma Q4 Earnings in Motion: What's Up?
Jan 18 / Zacks.com - Paid Partner Content
Merck's Keytruda on a Roll: Can it Retain the Spark in 2018?
Jan 12 / Zacks.com - Paid Partner Content
Merck Strong on Confirmatory Phase III Lung Cancer Study
Jan 17 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Novo Nordisk Reveals Bid to Acquire Ablynx, Pfizer & Others at ...
Jan 12 / Zacks.com - Paid Partner Content
7 Stocks Move in Premarket Trade Wednesday
Jan 17 / GuruFocus News - Paid Partner Content
Key Takeaways from Pfizer & 3 Other Drug Stocks at Healthcare Conference
Jan 11 / Zacks.com - Paid Partner Content
Juno's Stock High on Possible Acquisition
Jan 17 / GuruFocus News - Paid Partner Content
Big Pharma CEOs Speak About Impact of Tax Reform on M&A
Jan 11 / Zacks.com - Paid Partner Content
Ignore the Gaps and Merck Is Ready for Further Strong Gains
Jan 17 / TheStreet.com - Paid Partner Content
5 ETFs to Bet on 2018 Dogs of the Dow
Jan 10 / Zacks.com - Paid Partner Content
Merck (MRK) Jumps: Stock Rises 5.8%
Jan 17 / Zacks.com - Paid Partner Content
Novo Nordisk's Ozempic Gets Canadian Approval for Diabetes
Jan 10 / Zacks.com - Paid Partner Content
Dow Touches New Intraday High, Finishes Lower
Jan 16 / Zacks.com - Paid Partner Content
Merck's Keytruda Combo Gets Breakthrough Therapy Status
Jan 10 / Zacks.com - Paid Partner Content
With Social Media Use Set to Grow in 2018, Buy Twitter (TWTR)
Jan 16 / Zacks.com - Paid Partner Content
Amgen Announces Acceptance of MAA for Evenity in Europe
Jan 09 / Zacks.com - Paid Partner Content
PM CAPITAL Ltd Buys Wells Fargo, Ares Management LP, Blackstone Group LP, Sells Merck...
Jan 16 / GuruFocus News - Paid Partner Content
Merck's (MRK) Keytruda Succeeds in High-Risk Melanoma Study
Jan 09 / Zacks.com - Paid Partner Content
3 Biotech Stocks Start Healthy in '18: Will the Rally Last?
Jan 16 / Zacks.com - Paid Partner Content
Alzheimer's takes Another Hit as Pfizer Ends Research in this Area
Jan 08 / Zacks.com - Paid Partner Content
Graybill Bartz & Assoc Ltd Buys Halliburton Co, Intel Corp, iShares Core MSCI Emergin...
Jan 16 / GuruFocus News - Paid Partner Content
U.S. companies will pay billions in tax on offshore cash piles
Jan 02 / CNNMoney.com